Review



pe cy7 anti human cd4  (Cytek Biosciences)


Bioz Verified Symbol Cytek Biosciences is a verified supplier
Bioz Manufacturer Symbol Cytek Biosciences manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cytek Biosciences pe cy7 anti human cd4
    Pe Cy7 Anti Human Cd4, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pe cy7 anti human cd4/product/Cytek Biosciences
    Average 93 stars, based on 4 article reviews
    pe cy7 anti human cd4 - by Bioz Stars, 2026-03
    93/100 stars

    Images



    Similar Products

    95
    Miltenyi Biotec anti cd133 pe cy7 antibody
    Anti Cd133 Pe Cy7 Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd133 pe cy7 antibody/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    anti cd133 pe cy7 antibody - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    90
    Becton Dickinson anti-human cd4 pe-cy7
    Increased senescent T-cells in insulin-resistant ( IR ) women versus metabolically healthy controls ( HC ). Flow cytometry was used to test peripheral white blood cells (WBCs) from 9 insulin-resistant women (HbA1c = 5.7–6.3) vs. 13 metabolically healthy women (HbA1 < 5.7) for beta-galactosidase (SA-beta-gal) activity, a marker of senescence. There was a significant increase in the percentage of senescent <t>CD4+-</t> and CD8+-positive T-cells in insulin-resistant women vs. healthy women; ** p = 0.0046 and * p = 0.0245, respectively.
    Anti Human Cd4 Pe Cy7, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-human cd4 pe-cy7/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    anti-human cd4 pe-cy7 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher mouse anti-human cd4-pe-cy7
    Increased senescent T-cells in insulin-resistant ( IR ) women versus metabolically healthy controls ( HC ). Flow cytometry was used to test peripheral white blood cells (WBCs) from 9 insulin-resistant women (HbA1c = 5.7–6.3) vs. 13 metabolically healthy women (HbA1 < 5.7) for beta-galactosidase (SA-beta-gal) activity, a marker of senescence. There was a significant increase in the percentage of senescent <t>CD4+-</t> and CD8+-positive T-cells in insulin-resistant women vs. healthy women; ** p = 0.0046 and * p = 0.0245, respectively.
    Mouse Anti Human Cd4 Pe Cy7, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti-human cd4-pe-cy7/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    mouse anti-human cd4-pe-cy7 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Becton Dickinson mouse anti-human cd4/pe-cy7
    Increased senescent T-cells in insulin-resistant ( IR ) women versus metabolically healthy controls ( HC ). Flow cytometry was used to test peripheral white blood cells (WBCs) from 9 insulin-resistant women (HbA1c = 5.7–6.3) vs. 13 metabolically healthy women (HbA1 < 5.7) for beta-galactosidase (SA-beta-gal) activity, a marker of senescence. There was a significant increase in the percentage of senescent <t>CD4+-</t> and CD8+-positive T-cells in insulin-resistant women vs. healthy women; ** p = 0.0046 and * p = 0.0245, respectively.
    Mouse Anti Human Cd4/Pe Cy7, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti-human cd4/pe-cy7/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    mouse anti-human cd4/pe-cy7 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    93
    Cytek Biosciences pe cy7 anti human cd4
    Increased senescent T-cells in insulin-resistant ( IR ) women versus metabolically healthy controls ( HC ). Flow cytometry was used to test peripheral white blood cells (WBCs) from 9 insulin-resistant women (HbA1c = 5.7–6.3) vs. 13 metabolically healthy women (HbA1 < 5.7) for beta-galactosidase (SA-beta-gal) activity, a marker of senescence. There was a significant increase in the percentage of senescent <t>CD4+-</t> and CD8+-positive T-cells in insulin-resistant women vs. healthy women; ** p = 0.0046 and * p = 0.0245, respectively.
    Pe Cy7 Anti Human Cd4, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pe cy7 anti human cd4/product/Cytek Biosciences
    Average 93 stars, based on 1 article reviews
    pe cy7 anti human cd4 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    90
    Becton Dickinson anti-human cd4-pe-cy7
    Increased senescent T-cells in insulin-resistant ( IR ) women versus metabolically healthy controls ( HC ). Flow cytometry was used to test peripheral white blood cells (WBCs) from 9 insulin-resistant women (HbA1c = 5.7–6.3) vs. 13 metabolically healthy women (HbA1 < 5.7) for beta-galactosidase (SA-beta-gal) activity, a marker of senescence. There was a significant increase in the percentage of senescent <t>CD4+-</t> and CD8+-positive T-cells in insulin-resistant women vs. healthy women; ** p = 0.0046 and * p = 0.0245, respectively.
    Anti Human Cd4 Pe Cy7, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-human cd4-pe-cy7/product/Becton Dickinson
    Average 90 stars, based on 1 article reviews
    anti-human cd4-pe-cy7 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher anti-human cd4 pe cy7
    Increased senescent T-cells in insulin-resistant ( IR ) women versus metabolically healthy controls ( HC ). Flow cytometry was used to test peripheral white blood cells (WBCs) from 9 insulin-resistant women (HbA1c = 5.7–6.3) vs. 13 metabolically healthy women (HbA1 < 5.7) for beta-galactosidase (SA-beta-gal) activity, a marker of senescence. There was a significant increase in the percentage of senescent <t>CD4+-</t> and CD8+-positive T-cells in insulin-resistant women vs. healthy women; ** p = 0.0046 and * p = 0.0245, respectively.
    Anti Human Cd4 Pe Cy7, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-human cd4 pe cy7/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    anti-human cd4 pe cy7 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    SouthernBiotech mouse anti-human cd4-pe-cy7
    Increased senescent T-cells in insulin-resistant ( IR ) women versus metabolically healthy controls ( HC ). Flow cytometry was used to test peripheral white blood cells (WBCs) from 9 insulin-resistant women (HbA1c = 5.7–6.3) vs. 13 metabolically healthy women (HbA1 < 5.7) for beta-galactosidase (SA-beta-gal) activity, a marker of senescence. There was a significant increase in the percentage of senescent <t>CD4+-</t> and CD8+-positive T-cells in insulin-resistant women vs. healthy women; ** p = 0.0046 and * p = 0.0245, respectively.
    Mouse Anti Human Cd4 Pe Cy7, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti-human cd4-pe-cy7/product/SouthernBiotech
    Average 90 stars, based on 1 article reviews
    mouse anti-human cd4-pe-cy7 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher pe-cy7 conjugated anti–human cd4
    Targeted mutation of the Hif1a gene increased PDL1 levels in donor T cells and non-tumor host tissues via IFNγ-dependent pathway Flow cytometry analysis of spleen samples from WT or Hif1a −/− T cell recipients 14 days after transplantation. (A) The percentage of WT and Hif1a −/− donor T cell in splenocytes of 14 days post-transplantation mice, shown as mean ± SEM. Data are representative of 3 independent experiments. (B) Frequency of IFNγ + T cells in spleen. Splenocytes from recipients reconstituted with WT or Hif1a −/− T cells were stimulated with PMA + ionomycin for 4 h, and IFNγ expression was determined by intracellular staining. The summarized data are shown as mean ± SEM for one experiment and are representative of 3 independent experiments. (C) The mean fluorescence intensity (MFI) of PDL1 staining is plotted for <t>CD4</t> (left) and CD8 (right) donor T cells from spleens of recipient mice on day 14. (D) The CD4/CD8 ratio of donor WT and Hif1a −/− T cells in splenocytes of 14 days post-transplantation mice was measured and summarized, shown as mean ± SEM. Data are shown for one experiment and are representative of at least 3 independent experiments. (E) BALB/c mice received 5 × 10 6 CD45.1 T cell-depleted BM cells + 3 × 10 5 WT or Hif1a −/− T cells and were subsequently treated with anti-mouse IFNγ (XMG1.2) or isotype control IgG antibodies (vehicle). Representative immunofluorescence staining for CD3 and PDL1 in the liver and S.G. tissues from mice receiving different treatments. (F) Kaplan-Meier survival curves are shown for the four groups of mice. The data are representative of three experiments. (G) H&E-stained tissues are shown in representative images for each of four groups of mice, highlighting major pathological findings. (H) Summary of histological scoring for the organs in each group depicted in (H). Scoring criteria are described in the .
    Pe Cy7 Conjugated Anti–Human Cd4, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pe-cy7 conjugated anti–human cd4/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    pe-cy7 conjugated anti–human cd4 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher anti-human cd4-pe-cy7
    Targeted mutation of the Hif1a gene increased PDL1 levels in donor T cells and non-tumor host tissues via IFNγ-dependent pathway Flow cytometry analysis of spleen samples from WT or Hif1a −/− T cell recipients 14 days after transplantation. (A) The percentage of WT and Hif1a −/− donor T cell in splenocytes of 14 days post-transplantation mice, shown as mean ± SEM. Data are representative of 3 independent experiments. (B) Frequency of IFNγ + T cells in spleen. Splenocytes from recipients reconstituted with WT or Hif1a −/− T cells were stimulated with PMA + ionomycin for 4 h, and IFNγ expression was determined by intracellular staining. The summarized data are shown as mean ± SEM for one experiment and are representative of 3 independent experiments. (C) The mean fluorescence intensity (MFI) of PDL1 staining is plotted for <t>CD4</t> (left) and CD8 (right) donor T cells from spleens of recipient mice on day 14. (D) The CD4/CD8 ratio of donor WT and Hif1a −/− T cells in splenocytes of 14 days post-transplantation mice was measured and summarized, shown as mean ± SEM. Data are shown for one experiment and are representative of at least 3 independent experiments. (E) BALB/c mice received 5 × 10 6 CD45.1 T cell-depleted BM cells + 3 × 10 5 WT or Hif1a −/− T cells and were subsequently treated with anti-mouse IFNγ (XMG1.2) or isotype control IgG antibodies (vehicle). Representative immunofluorescence staining for CD3 and PDL1 in the liver and S.G. tissues from mice receiving different treatments. (F) Kaplan-Meier survival curves are shown for the four groups of mice. The data are representative of three experiments. (G) H&E-stained tissues are shown in representative images for each of four groups of mice, highlighting major pathological findings. (H) Summary of histological scoring for the organs in each group depicted in (H). Scoring criteria are described in the .
    Anti Human Cd4 Pe Cy7, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-human cd4-pe-cy7/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    anti-human cd4-pe-cy7 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Increased senescent T-cells in insulin-resistant ( IR ) women versus metabolically healthy controls ( HC ). Flow cytometry was used to test peripheral white blood cells (WBCs) from 9 insulin-resistant women (HbA1c = 5.7–6.3) vs. 13 metabolically healthy women (HbA1 < 5.7) for beta-galactosidase (SA-beta-gal) activity, a marker of senescence. There was a significant increase in the percentage of senescent CD4+- and CD8+-positive T-cells in insulin-resistant women vs. healthy women; ** p = 0.0046 and * p = 0.0245, respectively.

    Journal: Cancers

    Article Title: Insulin Resistance in Women Correlates with Chromatin Histone Lysine Acetylation, Inflammatory Signaling, and Accelerated Aging

    doi: 10.3390/cancers16152735

    Figure Lengend Snippet: Increased senescent T-cells in insulin-resistant ( IR ) women versus metabolically healthy controls ( HC ). Flow cytometry was used to test peripheral white blood cells (WBCs) from 9 insulin-resistant women (HbA1c = 5.7–6.3) vs. 13 metabolically healthy women (HbA1 < 5.7) for beta-galactosidase (SA-beta-gal) activity, a marker of senescence. There was a significant increase in the percentage of senescent CD4+- and CD8+-positive T-cells in insulin-resistant women vs. healthy women; ** p = 0.0046 and * p = 0.0245, respectively.

    Article Snippet: PBMCs (1.0 × 10 6 ) were prepared for flow cytometry by staining for the immune cell subsets, CD45+CD3+CD4+ T-cells, and CD45+CD3+CD8+ T-cells using anti-human CD45 V500 (BD Biosciences, Frankliin Lakes, NJ, USA, Catalog No. 560777), anti-human CD3 Super Bright 600 (ThermoFisher Scientific, Waltham, MA, USA, Catalog No. 63-0037-42), anti-human CD4 PE-Cy7 (BD Biosciences, Catalog No. 348789), and anti-human CD8 cFlourYG610 (Cytek Biosciences, Fremont, CA, USA, Catalog No. R7-20245).

    Techniques: Metabolic Labelling, Flow Cytometry, Activity Assay, Marker

    Targeted mutation of the Hif1a gene increased PDL1 levels in donor T cells and non-tumor host tissues via IFNγ-dependent pathway Flow cytometry analysis of spleen samples from WT or Hif1a −/− T cell recipients 14 days after transplantation. (A) The percentage of WT and Hif1a −/− donor T cell in splenocytes of 14 days post-transplantation mice, shown as mean ± SEM. Data are representative of 3 independent experiments. (B) Frequency of IFNγ + T cells in spleen. Splenocytes from recipients reconstituted with WT or Hif1a −/− T cells were stimulated with PMA + ionomycin for 4 h, and IFNγ expression was determined by intracellular staining. The summarized data are shown as mean ± SEM for one experiment and are representative of 3 independent experiments. (C) The mean fluorescence intensity (MFI) of PDL1 staining is plotted for CD4 (left) and CD8 (right) donor T cells from spleens of recipient mice on day 14. (D) The CD4/CD8 ratio of donor WT and Hif1a −/− T cells in splenocytes of 14 days post-transplantation mice was measured and summarized, shown as mean ± SEM. Data are shown for one experiment and are representative of at least 3 independent experiments. (E) BALB/c mice received 5 × 10 6 CD45.1 T cell-depleted BM cells + 3 × 10 5 WT or Hif1a −/− T cells and were subsequently treated with anti-mouse IFNγ (XMG1.2) or isotype control IgG antibodies (vehicle). Representative immunofluorescence staining for CD3 and PDL1 in the liver and S.G. tissues from mice receiving different treatments. (F) Kaplan-Meier survival curves are shown for the four groups of mice. The data are representative of three experiments. (G) H&E-stained tissues are shown in representative images for each of four groups of mice, highlighting major pathological findings. (H) Summary of histological scoring for the organs in each group depicted in (H). Scoring criteria are described in the .

    Journal: Cell Reports Medicine

    Article Title: Genetic and pharmaceutical targeting of HIF1α allows combo-immunotherapy to boost graft vs. leukemia without exacerbation graft vs. host disease

    doi: 10.1016/j.xcrm.2023.101236

    Figure Lengend Snippet: Targeted mutation of the Hif1a gene increased PDL1 levels in donor T cells and non-tumor host tissues via IFNγ-dependent pathway Flow cytometry analysis of spleen samples from WT or Hif1a −/− T cell recipients 14 days after transplantation. (A) The percentage of WT and Hif1a −/− donor T cell in splenocytes of 14 days post-transplantation mice, shown as mean ± SEM. Data are representative of 3 independent experiments. (B) Frequency of IFNγ + T cells in spleen. Splenocytes from recipients reconstituted with WT or Hif1a −/− T cells were stimulated with PMA + ionomycin for 4 h, and IFNγ expression was determined by intracellular staining. The summarized data are shown as mean ± SEM for one experiment and are representative of 3 independent experiments. (C) The mean fluorescence intensity (MFI) of PDL1 staining is plotted for CD4 (left) and CD8 (right) donor T cells from spleens of recipient mice on day 14. (D) The CD4/CD8 ratio of donor WT and Hif1a −/− T cells in splenocytes of 14 days post-transplantation mice was measured and summarized, shown as mean ± SEM. Data are shown for one experiment and are representative of at least 3 independent experiments. (E) BALB/c mice received 5 × 10 6 CD45.1 T cell-depleted BM cells + 3 × 10 5 WT or Hif1a −/− T cells and were subsequently treated with anti-mouse IFNγ (XMG1.2) or isotype control IgG antibodies (vehicle). Representative immunofluorescence staining for CD3 and PDL1 in the liver and S.G. tissues from mice receiving different treatments. (F) Kaplan-Meier survival curves are shown for the four groups of mice. The data are representative of three experiments. (G) H&E-stained tissues are shown in representative images for each of four groups of mice, highlighting major pathological findings. (H) Summary of histological scoring for the organs in each group depicted in (H). Scoring criteria are described in the .

    Article Snippet: PE-Cy7 conjugated anti–human CD4 , eBioscience , 25-0047-42; 25-0047-42.

    Techniques: Mutagenesis, Flow Cytometry, Transplantation Assay, Expressing, Staining, Fluorescence, Control, Immunofluorescence

    Journal: Cell Reports Medicine

    Article Title: Genetic and pharmaceutical targeting of HIF1α allows combo-immunotherapy to boost graft vs. leukemia without exacerbation graft vs. host disease

    doi: 10.1016/j.xcrm.2023.101236

    Figure Lengend Snippet:

    Article Snippet: PE-Cy7 conjugated anti–human CD4 , eBioscience , 25-0047-42; 25-0047-42.

    Techniques: Recombinant, Software